APPLICABILITY OF FLOW-CYTOMETRY IN BREAST-CANCER

被引：2
作者：
CLARK, GM
机构：
[1] Department of Medicine / Oncology, University of Texas Health Science Center at San Antonio, San Antonio, Texas
来源：
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES | 1993年 / 677卷
关键词：
D O I：
10.1111/j.1749-6632.1993.tb38792.x
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
[No abstract available]
引用
收藏
页码：379 / 383
页数：5
相关论文
共 23 条
[1]  
CLARK G M, 1990, Proceedings of the American Association for Cancer Research Annual Meeting, V31, P184
[2]   PREDICTION OF RELAPSE OR SURVIVAL IN PATIENTS WITH NODE-NEGATIVE BREAST-CANCER BY DNA FLOW-CYTOMETRY [J].
CLARK, GM ;
DRESSLER, LG ;
OWENS, MA ;
POUNDS, G ;
OLDAKER, T ;
MCGUIRE, WL .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (10) :627-633
[3]   PROGNOSTIC-SIGNIFICANCE OF S-PHASE FRACTION IN GOOD-RISK, NODE-NEGATIVE BREAST-CANCER PATIENTS [J].
CLARK, GM ;
MATHIEU, MC ;
OWENS, MA ;
DRESSLER, LG ;
EUDEY, L ;
TORMEY, DC ;
OSBORNE, CK ;
GILCHRIST, KW ;
MANSOUR, EG ;
ABELOFF, MD ;
MCGUIRE, WL .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (03) :428-432
[4]   DNA PLOIDY AND SURVIVAL IN BREAST-CANCER PATIENTS [J].
CORNELISSE, CJ ;
VANDEVELDE, CJH ;
CASPERS, RJC ;
MOOLENAAR, AJ ;
HERMANS, J .
CYTOMETRY, 1987, 8 (02) :225-234
[5]   BREAST-CANCER THERAPY - EXERCISING ALL OUR OPTIONS [J].
DEVITA, VT .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (08) :527-529
[6]   FLOW-CYTOMETRIC DNA ANALYSIS IN PRIMARY BREAST CARCINOMAS AND CLINICOPATHOLOGICAL CORRELATIONS [J].
EWERS, SB ;
LANGSTROM, E ;
BALDETORP, B ;
KILLANDER, D .
CYTOMETRY, 1984, 5 (04) :408-419
[7]   A RANDOMIZED CLINICAL-TRIAL EVALUATING SEQUENTIAL METHOTREXATE AND FLUOROURACIL IN THE TREATMENT OF PATIENTS WITH NODE-NEGATIVE BREAST-CANCER WHO HAVE ESTROGEN-RECEPTOR-NEGATIVE TUMORS [J].
FISHER, B ;
REDMOND, C ;
DIMITROV, NV ;
BOWMAN, D ;
LEGAULTPOISSON, S ;
WICKERHAM, DL ;
WOLMARK, N ;
FISHER, ER ;
MARGOLESE, R ;
SUTHERLAND, C ;
GLASS, A ;
FOSTER, R ;
CAPLAN, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (08) :473-478
[8]   A RANDOMIZED CLINICAL-TRIAL EVALUATING TAMOXIFEN IN THE TREATMENT OF PATIENTS WITH NODE-NEGATIVE BREAST-CANCER WHO HAVE ESTROGEN-RECEPTOR POSITIVE TUMORS [J].
FISHER, B ;
COSTANTINO, J ;
REDMOND, C ;
POISSON, R ;
BOWMAN, D ;
COUTURE, J ;
DIMITROV, NV ;
WOLMARK, N ;
WICKERHAM, DL ;
FISHER, ER ;
MARGOLESE, R ;
ROBIDOUX, A ;
SHIBATA, H ;
TERZ, J ;
PATERSON, AHG ;
FELDMAN, MI ;
FARRAR, W ;
EVANS, J ;
LICKLEY, HL ;
KETNER, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (08) :479-484
[9]   TUMOR DNA PLOIDY AS AN INDEPENDENT PROGNOSTIC FACTOR IN BREAST-CANCER [J].
KALLIONIEMI, OP ;
BLANCO, G ;
ALAVAIKKO, M ;
HIETANEN, T ;
MATTILA, J ;
LAUSLAHTI, K ;
KOIVULA, T .
BRITISH JOURNAL OF CANCER, 1987, 56 (05) :637-642
[10]  
KALLIONIEMI OP, 1988, CANCER, V62, P2183, DOI 10.1002/1097-0142(19881115)62:10<2183::AID-CNCR2820621019>3.0.CO
123